Contraceptive efficacy and global licensing of 52 mg levonorgestrel intrauterine devices: does a Mirena last longer in New York than York?

被引：0
|
作者：
Nash, Zachary [1 ,2 ,4 ]
Thwaites, Annette [2 ,3 ]
机构：
[1] Univ Coll London Hosp, Reprod Med Unit, London, England
[2] Univ Coll London Hosp, EGA Inst Womens Hlth, London, England
[3] Kings Coll Hosp NHS Fdn Trust, Sexual & Reprod Hlth, London, England
[4] UCL, Dept Gynaecol, London WC1E 6BT, England
来源：
BMJ SEXUAL & REPRODUCTIVE HEALTH | 2024年 / 50卷 / 01期
关键词：
D O I：
10.1136/bmjsrh-2023-201937
中图分类号：
D669 [社会生活与社会问题]; C913 [社会生活与社会问题];
学科分类号：
1204 ;
摘要：
引用
收藏
页码：4 / 6
页数：3
相关论文
共 10 条
  • [1] Contraceptive efficacy and safety of the 52-mg levonorgestrel intrauterine system for up to 8 years: findings from the Mirena Extension Trial
    Jensen, Jeffrey T.
    Lukkari-Lax, Eeva
    Schulze, Andrea
    Wahdan, Yesmean
    Serrani, Marco
    Kroll, Robin
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 227 (06) : 873.e1 - 873.e12
  • [2] Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System
    Teal, Stephanie B.
    Turok, David K.
    Chen, Beatrice A.
    Kimble, Thomas
    Olariu, Andrea, I
    Creinin, Mitchell D.
    OBSTETRICS AND GYNECOLOGY, 2019, 133 (01): : 63 - 70
  • [3] Six-year contraceptive efficacy and continued safety of a levonorgestrel 52 mg intrauterine system
    Westhoff, Carolyn L.
    Keder, Lisa M.
    Gangestad, Angelina
    Teal, Stephanie B.
    Olariu, Andrea I.
    Creinin, Mitchell D.
    CONTRACEPTION, 2020, 101 (03) : 159 - 161
  • [4] Contraceptive Efficacy and Safety of 52 mg Levonorgestrel-Releasing Intrauterine Systems During Years 6-8 of Use: Data From the Mirena Extension Trial
    Jensen, Jeffrey T.
    OBSTETRICS AND GYNECOLOGY, 2022, 139 : 4S - 4S
  • [5] Levonorgestrel 52-mg Intrauterine Device Efficacy and Safety After More Than 8 Years of Use
    Chen, Beatrice A.
    Kimble, Thomas
    Harris, Lisa H.
    Kerns, Jennifer L.
    Olariu, Andrea I.
    Creinin, Mitchell D.
    OBSTETRICS AND GYNECOLOGY, 2023, 141 (05): : 1004 - 1006
  • [6] Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system
    Eisenberg, David L.
    Schreiber, Courtney A.
    Turok, David K.
    Teal, Stephanie B.
    Westhoff, Carolyn L.
    Creinin, Mitchell D.
    CONTRACEPTION, 2015, 92 (01) : 10 - 16
  • [7] Five-year Contraceptive Use of 52-mg Levonorgestrel Releasing Intrauterine System in Young Women, Menstrual Patterns, and New Contraceptive Choice
    de Oliveira, Elaine Cristina Fontes
    Rocha, Ana Luiza Lunardi
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2023, 45 (11): : 654 - 660
  • [8] A RANDOMIZED PHASE III STUDY COMPARING A NEW 13.5 MG LEVONORGESTREL INTRAUTERINE CONTRACEPTIVE SYSTEM WITH A COMBINED ORAL CONTRACEPTIVE: ANALYSIS OF EFFICACY AND BLEEDING PROFILES.
    Borgatta, L.
    Roth, K.
    Reowski, S.
    Rosen, K.
    FERTILITY AND STERILITY, 2014, 102 (03) : E143 - E143
  • [9] Does a Bleeding Disorder Lessen the Efficacy of the 52-mg Levonorgestrel-Releasing Intrauterine System for Heavy Menstrual Bleeding in Adolescents? A Retrospective Multicenter Study
    Khalighi, Misha
    Wheeler, Allison P.
    Adeyemi-Fowode, Oluyemisi A.
    Kouides, Peter A.
    Durazo-Arvizu, Ramon A.
    Haley, Kristina
    Dersch, Candice M.
    Weyand, Angela C.
    Baldwin, Maureen K.
    Borzutzky, Claudia
    JOURNAL OF ADOLESCENT HEALTH, 2022, 71 (02) : 204 - 209
  • [10] A PHASE III SINGLE-ARM STUDY OF A NEW 13.5 MG LEVONORGESTREL INTRAUTERINE CONTRACEPTIVE SYSTEM IN POSTMENARCHEAL ADOLESCENTS: AN EVALUATION OF EFFICACY, BLEEDING, USER SATISFACTION, AND PLACEMENT.
    Gemzell-Danielsson, K.
    Dermout, S.
    Lukkari-Lax, E.
    Montegriffo, E.
    Rybowski, S.
    Apter, D.
    FERTILITY AND STERILITY, 2014, 102 (03) : E141 - E142
1